Gilead Sciences to Present at the Annual Piper Jaffray Healthcare Conference on Tuesday, November 29
November 15 2016 - 05:00PM
Business Wire
Webcast Available Through Gilead Corporate
Website
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John
F. Milligan, PhD, Gilead’s President and Chief Executive Officer,
and Robin L. Washington, Gilead’s Executive Vice President and
Chief Financial Officer, will participate in a fireside chat at the
Annual Piper Jaffray Healthcare Conference in New York on Tuesday,
November 29 at 8:00 a.m. Eastern Time.
The audio portion of the fireside chat will be accessible live
through the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior
to the start of the presentation to ensure adequate time for any
software download that may be required to listen to the webcast.
The replay will be available for 14 days following the
presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161115006392/en/
Gilead Sciences, Inc.Sung Lee, 650-524-7792Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2023 to Mar 2024